Aslan Pharmaceuticals Ltd Stock Analysis

Aslan Stock Analysis Notes

About 15.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.75. Aslan Pharmaceuticals had not issued any dividends in recent years. The entity had 1:5 split on the 13th of March 2023. ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company was founded in 2010 and is headquartered in Singapore. Aslan Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. For more info on Aslan Pharmaceuticals Ltd please contact Carl Firth at 65 6817 9598 or go to https://aslanpharma.com.

Aslan Pharmaceuticals Investment Alerts

Aslan Pharmaceuticals Upcoming and Recent Events

Aslan Largest EPS Surprises

View All Earnings Estimates

Aslan Stock Institutional Investors

Note, although Aslan Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aslan Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aslan Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aslan Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Aslan Profitablity

Management Efficiency

Aslan Pharmaceuticals has return on total asset (ROA) of (0.6371) % which means that it has lost $0.6371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.2664) %, meaning that it created substantial loss on money invested by shareholders. Aslan Pharmaceuticals' management efficiency ratios could be used to measure how well Aslan Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of April 2024, Return On Tangible Assets is likely to drop to -1.89. In addition to that, Return On Capital Employed is likely to grow to -3.61. At this time, Aslan Pharmaceuticals' Total Assets are very stable compared to the past year. As of the 18th of April 2024, Other Current Assets is likely to grow to about 2.8 M, while Net Tangible Assets are likely to drop about 7.1 M.

Technical Drivers

As of the 18th of April 2024, Aslan Pharmaceuticals shows the Risk Adjusted Performance of 0.0355, mean deviation of 10.06, and Downside Deviation of 14.17. Aslan Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Aslan Pharmaceuticals Ltd, which can be compared to its peers. Please confirm Aslan Pharmaceuticals downside deviation, jensen alpha, as well as the relationship between the Jensen Alpha and downside variance to decide if Aslan Pharmaceuticals is priced correctly, providing market reflects its regular price of 0.54 per share. As Aslan Pharmaceuticals is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Aslan Pharmaceuticals Price Movement Analysis

Aslan Pharmaceuticals Predictive Daily Indicators

Aslan Pharmaceuticals Forecast Models

Aslan Pharmaceuticals' time-series forecasting models are one of many Aslan Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aslan Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aslan Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aslan shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aslan Pharmaceuticals. By using and applying Aslan Stock analysis, traders can create a robust methodology for identifying Aslan entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aslan analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aslan analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Aslan Pharmaceuticals Ltd stock analysis indicators help investors evaluate how Aslan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aslan Pharmaceuticals shares will generate the highest return on investment. By understating and applying Aslan Pharmaceuticals stock analysis, traders can identify Aslan Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aslan Pharmaceuticals Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

When running Aslan Pharmaceuticals' price analysis, check to measure Aslan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aslan Pharmaceuticals is operating at the current time. Most of Aslan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aslan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aslan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aslan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Aslan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aslan Pharmaceuticals. If investors know Aslan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aslan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Aslan Pharmaceuticals is measured differently than its book value, which is the value of Aslan that is recorded on the company's balance sheet. Investors also form their own opinion of Aslan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aslan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aslan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aslan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aslan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aslan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aslan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.